Drug Discovery News
-
Linaclotide phase III trial initiated in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2013
Singapore: Ironwood Pharmaceuticals and AstraZeneca Pharmaceuticals have announced the initiation of a phase III clinica...Read more
-
Singapore firm, Stehlin Foundation collaborate on anti-cancer drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Oct, 2013
Singapore: NanoMaterials Technology (NMT), a Singapore based company, has signed an exclusive material supply agreement ...Read more
-
AseaCyte gets BioSpectrum award for drug discovery efforts
Drug Discovery | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundatio...Read more
-
Abraxane cancer trial shows positive results in Australia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: Specialised Therapeutics Australia (STA) is going to publish abstracts related to its phase III metastatic me...Read more
-
Astellas, Ambit terminate cancer drug deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2013
Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...Read more
-
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2013
Singapore: Roche has launched FLOW system, a user defined system for workflow chain from primary sample handling to qPCR...Read more
-
TB prevention faces gap of $1.6bn: WHO estimates
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...Read more
-
Edison Pharma, DSP enter $4 bn metablosim drug deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2014
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...Read more
-
Gilead files NDA for Hep C drug in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jun, 2014
Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Dev...Read more
-
GSK gets EU nod for metastatic melanoma inhibitor
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: GlaxoSmithKline has recieved European Commission (EC) marketing authorisation for Mekinist (trametinib) as a ...Read more
-
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed...Read more
-
Merck Millipore enhances bioavailability portfolio
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2012
Singapore: Merck Millipore is boosting its portfolio for drug bioavailability, including products for all types of dosag...Read more
-
Singapore scientists, clinicians collaborate on 8 projects
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Singapore has announced 8 biomedical sciences research programmes to advance understanding and treatment of d...Read more
-
Boehringer Ingelheim enriches drug pipeline
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012
Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of ...Read more
-
China will overtake Japan in R&D spending: Report
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2013
Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, inve...Read more
-
Astellas gets FDA nod for kidney transplant drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsule...Read more
-
Global collaborations is the way forward for drug discovery
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry ser...Read more
-
NIH gives $2.2 mn to VaxInnate for dengue vaccine
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2013
Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provi...Read more
